Lab Research Products
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
120
NCT06478719
To Evaluate Safety and Efficacy of FB-1603 in Hepatocellular Carcinoma Patient Receiving Transarterial Chemoembolization
Phase: Phase 1/2
Role: Lead Sponsor
Start: Jun 24, 2024
Completion: Aug 6, 2027
Loading map...